Clinical trial

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell…

NCT00368355 · Baylor College of Medicine, Other · Completed

Key facts

NCT number NCT00368355
Title T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
Official title CD-34 Selection for Ex-vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Receiving Intensive Conditioning
Acronym MOHEL
Lead sponsor Baylor College of Medicine, Other
Collaborators Center for Cell and Gene Therapy, Baylor College of Medicine The Methodist Hospital Research Institute
Status Completed
Phase Phase 2
Study type Interventional
Conditions Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, Hemophagocytic Lymphohistiocytosis (HLH), Familial Hemophagocytic Lymphohistiocytosis (FLH), Viral-associated Hemophagocytic Syndrome (VAHS), X-linked Lymphoproliferative Disease (XLP)
Intervention type Biological, Drug, Procedure, Radiation
Interventions Ara-C, Cyclophosphamide, Campath-1H, Total Body Irradiation, Stem Cell Infusion
Enrollment 46
Start date Apr 1, 2000
Primary completion Nov 1, 2015
Completion Nov 1, 2016
First posted Aug 24, 2006
Last update posted Jan 21, 2020
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies